RE:RE:RE:HypotheticalI totally agree with you BellEnd if they win this judgement they will not only get the rights to Asia back they will most likely receive compensation related to the missed milestone payments. I would also assume Shiseido will have to turn over to Replicel all Trial results including this latest Trial data.
With that in mind when the hearing is announced Shiseido will be advised by there lawyers to settle with Replicel in order to not loose everything.
If and when this happens it will be a big day for the Replicel share price. For all those dreamers lets refrain from talking about $10.00 - $20.00 share prices. That first day we may see $1.00+. After that depending on the size of the settlement it will build from there. Also around the same time we should hear that the Dermaprecise has been submitted for FDA Approval . This should take us closer to $2.00+ After that we should see a slow build.
Again speculating if we see both of these events take place Replicel will be in the crosshairs of big pharma and sky is the limit.